LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020.

    Heaney, Alexandra K / Head, Jennifer R / Broen, Kelly / Click, Karen / Taylor, John / Balmes, John R / Zelner, Jon / Remais, Justin V

    Emerging infectious diseases

    2021  Volume 27, Issue 5, Page(s) 1266–1273

    Abstract: ... implications of co-infection, including severe COVID-19 and reactivation of latent coccidioidomycosis ... We review the interaction between coronavirus disease (COVID-19) and coccidioidomycosis ... similar symptoms, the COVID-19 pandemic might exacerbate delays in coccidioidomycosis diagnosis ...

    Abstract We review the interaction between coronavirus disease (COVID-19) and coccidioidomycosis, a respiratory infection caused by inhalation of Coccidioides fungal spores in dust. We examine risk for co-infection among construction and agricultural workers, incarcerated persons, Black and Latino populations, and persons living in high dust areas. We further identify common risk factors for co-infection, including older age, diabetes, immunosuppression, racial or ethnic minority status, and smoking. Because these diseases cause similar symptoms, the COVID-19 pandemic might exacerbate delays in coccidioidomycosis diagnosis, potentially interfering with prompt administration of antifungal therapies. Finally, we examine the clinical implications of co-infection, including severe COVID-19 and reactivation of latent coccidioidomycosis. Physicians should consider coccidioidomycosis as a possible diagnosis when treating patients with respiratory symptoms. Preventive measures such as wearing face masks might mitigate exposure to dust and severe acute respiratory syndrome coronavirus 2, thereby protecting against both infections.
    MeSH term(s) Aged ; COVID-19 ; Coccidioidomycosis/epidemiology ; Coinfection ; Ethnicity ; Humans ; Minority Groups ; Pandemics ; SARS-CoV-2 ; United States/epidemiology
    Language English
    Publishing date 2021-03-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid2705.204661
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020

    Alexandra K. Heaney / Jennifer R. Head / Kelly Broen / Karen Click / John Taylor / John R. Balmes / Jon Zelner / Justin V. Remais

    Emerging Infectious Diseases, Vol 27, Iss 5, Pp 1266-

    2021  Volume 1273

    Abstract: ... implications of co-infection, including severe COVID-19 and reactivation of latent coccidioidomycosis ... We review the interaction between coronavirus disease (COVID-19) and coccidioidomycosis ... similar symptoms, the COVID-19 pandemic might exacerbate delays in coccidioidomycosis diagnosis ...

    Abstract We review the interaction between coronavirus disease (COVID-19) and coccidioidomycosis, a respiratory infection caused by inhalation of Coccidioides fungal spores in dust. We examine risk for co-infection among construction and agricultural workers, incarcerated persons, Black and Latino populations, and persons living in high dust areas. We further identify common risk factors for co-infection, including older age, diabetes, immunosuppression, racial or ethnic minority status, and smoking. Because these diseases cause similar symptoms, the COVID-19 pandemic might exacerbate delays in coccidioidomycosis diagnosis, potentially interfering with prompt administration of antifungal therapies. Finally, we examine the clinical implications of co-infection, including severe COVID-19 and reactivation of latent coccidioidomycosis. Physicians should consider coccidioidomycosis as a possible diagnosis when treating patients with respiratory symptoms. Preventive measures such as wearing face masks might mitigate exposure to dust and severe acute respiratory syndrome coronavirus 2, thereby protecting against both infections.
    Keywords COVID-19 ; coccidioidomycosis ; co-infections ; diagnosis ; risk factors ; SARS-CoV-2 ; Medicine ; R ; Infectious and parasitic diseases ; RC109-216
    Subject code 610
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Centers for Disease Control and Prevention
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top